MedPath

GD-AZITHROMYCIN

GD-AZITHROMYCIN

Discontinued
DIN Number

02274574

Drug Class

Human

Market Date

Nov 4, 2013

Company
HC

genmed a division of pfizer canada ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02274574
AIG Number0126072003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FA10 AZITHROMYCIN
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
AHFS Classification08:12.12.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

AZITHROMYCINActive
Strength: 200 MG / 5 ML
Monograph: AZITHROMYCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.